Therapy Focus - First-Line Lung Cancer Is An Opdivo Vs. Keytruda Showdown

… checkpoint inhibitors in non-small cell lung cancer emerged at Asco, but none … immuno-oncology trials in non-small cell lung cancer Project/company Enrolment Study name …